Drug launch prices are outpacing their worth, with only one of 26 new drugs meeting ICER's value benchmark.
endpoints.newsNew ICER report suggests drug launch prices are outpacing their worthICER report: Median drug launch prices rose 24% from 2022-2025, net prices up 35%. Only 1 of 26 drugs met value benchmarks, causing $1B+ in excess spending.
1 repost1 like